189 related articles for article (PubMed ID: 33672032)
1. Aldehyde Dehydrogenase, a Therapeutic Target in Chordoma: Analysis in 3D Cellular Models.
Locquet MA; Dechaume AL; Berchard P; Abbes L; Pissaloux D; Tirode F; Ramos I; Bedoucha J; Valantin J; Karanian M; Perret R; Gille O; Blay JY; Dutour A
Cells; 2021 Feb; 10(2):. PubMed ID: 33672032
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of a chordoma cell line from the tissue of a patient with dedifferentiated-type chordoma.
Kim JY; Lee J; Koh JS; Park MJ; Chang UK
J Neurosurg Spine; 2016 Nov; 25(5):626-635. PubMed ID: 27314550
[TBL] [Abstract][Full Text] [Related]
3. UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.
Owen JH; Komarck CM; Wang AC; Abuzeid WM; Keep RF; McKean EL; Sullivan S; Fan X; Prince MEP
J Neurosurg; 2018 Mar; 128(3):701-709. PubMed ID: 28430034
[TBL] [Abstract][Full Text] [Related]
4. Molecular features and vulnerabilities of recurrent chordomas.
Seeling C; Lechel A; Svinarenko M; Möller P; Barth TFE; Mellert K
J Exp Clin Cancer Res; 2021 Jul; 40(1):244. PubMed ID: 34330313
[TBL] [Abstract][Full Text] [Related]
5. Plasticity within Aldehyde Dehydrogenase-Positive Cells Determines Prostate Cancer Radiosensitivity.
Schwarz FM; Schniewind I; Besso MJ; Lange S; Linge A; Patil SG; Löck S; Klusa D; Dietrich A; Voss-Böhme A; Nowrouzi A; Krause M; Dubrovska A; Kurth I; Peitzsch C
Mol Cancer Res; 2022 May; 20(5):794-809. PubMed ID: 35135863
[TBL] [Abstract][Full Text] [Related]
6. Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution.
van Wulfften Palthe ODR; Tromp I; Ferreira A; Fiore A; Bramer JAM; van Dijk NC; DeLaney TF; Schwab JH; Hornicek FJ
Spine J; 2019 May; 19(5):869-879. PubMed ID: 30445184
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells.
Cojoc M; Peitzsch C; Kurth I; Trautmann F; Kunz-Schughart LA; Telegeev GD; Stakhovsky EA; Walker JR; Simin K; Lyle S; Fuessel S; Erdmann K; Wirth MP; Krause M; Baumann M; Dubrovska A
Cancer Res; 2015 Apr; 75(7):1482-94. PubMed ID: 25670168
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary metastatic chordoma improved by platinum-based chemotherapy.
Lee MH; Kim SR; Jeong JS; Lee EJ; Lee YC
Lung Cancer; 2012 May; 76(2):255-7. PubMed ID: 22398139
[TBL] [Abstract][Full Text] [Related]
9. Surgical Strategies for Chordoma.
Bongers MER; Dea N; Ames CP; Schwab JH
Neurosurg Clin N Am; 2020 Apr; 31(2):251-261. PubMed ID: 32147016
[TBL] [Abstract][Full Text] [Related]
10. [Chordoma].
George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
[TBL] [Abstract][Full Text] [Related]
11. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases.
Fleming GF; Heimann PS; Stephens JK; Simon MA; Ferguson MK; Benjamin RS; Samuels BL
Cancer; 1993 Aug; 72(3):714-8. PubMed ID: 8334623
[TBL] [Abstract][Full Text] [Related]
12. Nanog Signaling Mediates Radioresistance in ALDH-Positive Breast Cancer Cells.
Dehghan Harati M; Rodemann HP; Toulany M
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845764
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
Kurth I; Hein L; Mäbert K; Peitzsch C; Koi L; Cojoc M; Kunz-Schughart L; Baumann M; Dubrovska A
Oncotarget; 2015 Oct; 6(33):34494-509. PubMed ID: 26460734
[TBL] [Abstract][Full Text] [Related]
14. Chordomas: A review with emphasis on their pathophysiology, pathology, molecular biology, and genetics.
Karpathiou G; Dumollard JM; Dridi M; Dal Col P; Barral FG; Boutonnat J; Peoc'h M
Pathol Res Pract; 2020 Sep; 216(9):153089. PubMed ID: 32825957
[TBL] [Abstract][Full Text] [Related]
15. Spinal chordomas dedifferentiated to osteosarcoma: a report of two cases and a literature review.
Kato S; Gasbarrini A; Ghermandi R; Gambarotti M; Bandiera S
Eur Spine J; 2016 May; 25 Suppl 1():251-6. PubMed ID: 27052403
[TBL] [Abstract][Full Text] [Related]
16. Blockage of Stat3 with CDDO-Me inhibits tumor cell growth in chordoma.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Choy E; Mankin H; Duan Z
Spine (Phila Pa 1976); 2010 Aug; 35(18):1668-75. PubMed ID: 20386502
[TBL] [Abstract][Full Text] [Related]
17. Characterization of FaDu-R, a radioresistant head and neck cancer cell line, and cancer stem cells.
Cho KJ; Park EJ; Kim MS; Joo YH
Auris Nasus Larynx; 2018 Jun; 45(3):566-573. PubMed ID: 28844650
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse.
Fagundes MA; Hug EB; Liebsch NJ; Daly W; Efird J; Munzenrider JE
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):579-84. PubMed ID: 7558946
[TBL] [Abstract][Full Text] [Related]
19. Hand metastasis from a sacral chordoma.
Emori M; Kaya M; Sugita S; Soma T; Sasaki M; Yamashita T
Ann R Coll Surg Engl; 2014 Nov; 96(8):e8-11. PubMed ID: 25350167
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma.
Hof H; Welzel T; Debus J
Onkologie; 2006 Dec; 29(12):572-4. PubMed ID: 17202828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
